About this trial

The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.

Eligibility criteria

Qualifiers

(specific to each study)

Disqualifiers

pregnant women <18 years old at recruitment

negative fetal heart at recruitment

women not able to provide an informed consent to the study

Trial design

Treatments tested in this trial

  • Observational

Treatment groups

7,845 Participants
are divided into 5 treatment groups

Locations

1
CHU de QuebecG1V 4G2, Québec Canada

Sponsors and collaborators

CHU de Quebec-Universite Laval

Lead sponsor